Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 254-751-6 | CAS number: 40018-26-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2004-07-12 to 2004-08-12
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 005
- Report date:
- 2005
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Version / remarks:
- adopted 24 April, 2002
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- mouse local lymph node assay (LLNA)
Test material
- Reference substance name:
- 1,4-dithiane-2,5-diol
- EC Number:
- 254-751-6
- EC Name:
- 1,4-dithiane-2,5-diol
- Cas Number:
- 40018-26-6
- Molecular formula:
- C4H8O2S2
- IUPAC Name:
- 1,4-dithiane-2,5-diol
- Test material form:
- solid: particulate/powder
Constituent 1
In vivo test system
Test animals
- Species:
- mouse
- Strain:
- CBA/Ca
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Females (if applicable) nulliparous and non-pregnant: yes
- Age at study initiation: 8-12 weeks
- Weight at study initiation: 15-23 g
- Housing: individually housed in suspended solid-floor polypropylene cages furnished with softwood woodflakes
- Diet (e.g. ad libitum): ad libitum; Certified Rat and Mouse Diet (Code 5LF2) supplied by BCM IPS Limited, London, UK
- Water (e.g. ad libitum): ad libitum
- Acclimation period: at least five days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 19-23
- Humidity (%): 30-70
- Air changes (per hr): 15
- Photoperiod (hrs dark / hrs light): 12/12
Study design: in vivo (LLNA)
- Vehicle:
- dimethylformamide
- Concentration:
- 5, 10, 25% (w/w)
- No. of animals per dose:
- 5
- Details on study design:
- PRE-SCREEN TESTS:
One female mouse was treated by daily application of 25 µl of the test material at a concentration of 25% (w/w) in dimethyl formamide to the dorsal surface of each ear for three consecutive days (Days 1, 2, 3). The mouse was observed twice daily on Days 1, 2 and 3 and once daily on Days 4, 5 and 6. There were no signs of systemic toxicity or excessive local irritation, only on days 2 and 3 residual test material was noted on the ears one hour post dosing. Based on these results the dose levels selected for the main test were 5%, 10% and 25 % (w/w).
MAIN STUDY
ANIMAL ASSIGNMENT AND TREATMENT
- Name of test method: In a mouse LLNA groups of 5 mice were treated with the test material at concentrations of 5, 10 and 25% (w/w) in dimethyl formamide. The mice were treated by daily application of 25 µl of the appropriate concentration of the test material to the dorsal surface of each ear for three consecutive days (Days 1, 2, 3). The test material formulation was administered using an automatic micropipette and spread over the dorsal surface of the ear using the tip of the pipette. Five days following the first topical application of the test material (Day 6) all mice were injected via the tail vein with 250 µl of phosphate buffered saline (PBS) containing ³H-methyl thymidine (³HTdR:80µCi/ml, specific activity 2.0 Ci/mmol. Five hours after administration the mice were killed and the lymph node cells were prepared by gentle mechanical disaggregation, several washing steps and resuspension in 5% Trichloroacetic acid in order to precipitate out the radioactive material. After an over night incubation cells were centrifuged and transferred to 10 mL scintillation fluid. The ³HTdR incorporation was measured by β-scintillation
- Criteria used to consider a positive response: The test material will be regarded as a sensitiser if at least one concentration of the test material results in a threefold or greater increase in ³HTdR incorporation compared to control values. Any test material failing to produce a threefold or greater increase in ³HTdR incorporation will be classified as a "non-sensitiser".
TREATMENT PREPARATION AND ADMINISTRATION: For the purpose of the study the test material was freshly prepared in dimethyl formamide. This vehicle was chosen as it produced the highest concentration that was suitable for dosing. The mice were treated by daily application of 25 µl of the appropriate concentration of the test material to the dorsal surface of each ear for three consecutive days (Days 1, 2, 3). - Positive control substance(s):
- hexyl cinnamic aldehyde (CAS No 101-86-0)
- Statistics:
- Data was processed to give group mean values for dpm and standard deviations where appropriate. Individual and group mean dpm values were assessed for dose response relationships by analysis of homogeneity of variance followed by one way analysis of variance (ANOVA). In the event of a significant result from the ANOVA, pairwise comparisons were performed between control and treated groups. For homogenous datasets Dunnett’s Multiple Comparison test was used and for non-homogenous datasets Dunnett’s T3 Multiple Comparison Method was used.
Results and discussion
- Positive control results:
- Results of the latest positive control:
5, 10, 25% (v/v) in acetone/olive oil: SI = 1.40, 2.23, 6.09*
*an SI of greater than 3.0 indicates a positive result
In vivo (LLNA)
Resultsopen allclose all
- Key result
- Parameter:
- SI
- Value:
- 16.36
- Test group / Remarks:
- 5% test material
- Key result
- Parameter:
- SI
- Value:
- 21.51
- Test group / Remarks:
- 10% test material
- Key result
- Parameter:
- SI
- Value:
- 17.63
- Test group / Remarks:
- 25% test material
- Cellular proliferation data / Observations:
- DETAILS ON STIMULATION INDEX CALCULATION
The proliferation response of lymph node cells was expressed as the number of radioactive disintegrations per minute per lymph nodes from each individual animal and as the ratio of ³HTdR incorporation into lymph node cells of test nodes relative to that recorded for the control nodes (Stimulation Index (SI)).
CLINICAL OBSERVATIONS:
There were no deaths. No signs of systemic toxicity were noted in the test or control animals during the study. Residual test material was noted on the ears of the animals treated with the test material at a concentration of 25% w/w in dimethyl formamide one hour post dosing on Days 2 and 3.
BODY WEIGHTS
Bodyweight changes of the test animals between Day 1 and Day 6 were comparable to those observed in the corresponding control group animals over the same period.
Any other information on results incl. tables
Table 1: Results of Local Lymph Node Assay (LLNA): Stimulation Index
Sample Description Test or Control Group |
Vehicle |
Low |
Medium |
High |
Stimulation Index (SI) |
N/A |
16.36 |
21.51 |
17.63 |
EC3b |
|
0.9168 |
1.39 |
4.254 |
b) The Estimated Concentration Three (EC3) is the minimum concentration of a test substance required to elicit a sensitization reaction (produce a stimulation index of three).
SI = Group Mean DPM
EC3 = C + [ (3-D) / (B-D) ] * (A-C)
Where (C,D) are values directly below SI of 3 (C = concentration, D = SI)
and (A,B) are the values above SI of 3 (A = concentration, B = SI)
Table 2: EC3 value obtained by log-linear extrapolation:
Sample Description Test or Control Group |
Vehicle |
Low |
Medium |
High |
Stimulation Index (SI) |
N/A |
16.36 |
21.51 |
17.63 |
EC3c |
|
|
0.852 |
5.1823E-07 |
c) Since all measured values exhibited a SI of far above 3 the EC3 value should be obtained by log-linear extrapolation (Ryan et al., 2007) according to the following formula:
EC3ex = 2^[log2 (c) + (3 -d)/(b-d) x (log2 (a) - log2 (c))]
where the point with the value higher than the smallest SI above 3 is denoted (a, b) and the point with the value lower than the smallest SI above 3 is denoted (c, d).
Ryan, Cindy A., et al. "Extrapolating local lymph node assay EC3 values to estimate relative sensitizing potency."Cutaneous and ocular toxicology 26(2) (2007): 135-145.
Applicant's summary and conclusion
- Interpretation of results:
- Category 1A (indication of significant skin sensitising potential) based on GHS criteria
- Conclusions:
- In the present study conducted according to OECD guideline 429 (adopted 24 April 2002), in sum 20 mice of the CBA/Ca strain were dermally exposed to 0, 5, 10 and 25% (w/w) test substance in dimethyl formamide, to the dorsal surface of each ear for three consecutive days (Days 1, 2, 3). After 5 days following the first topical application the mice were injected with 250 µl PBS containing ³H-methyl-thymidine (2 Ci/mmol). After further 5 h the lymph nodes were dissected and the cells prepared in order to determine the ³HTdR incorporation. Since the Stimulation Index (SI) was above a three-fold increase at every concentration tested and the EC3 obtained by log-linear extrapolation was below 2%, the test item is considered to be a sensitizer based on the obtained results. Thus, the substance needs to be classified as skin sensitizer Category 1A according to Regulation (EC) No 1272/2008 (CLP) and the Globally Harmonized System for Classification and Labelling of Chemicals (GHS).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.